September 11, 2011 — Genesis Biosystems, a leader in innovations for regeneration, today introduced its new DermaFrac system.
DermaFrac is a patent-pending, dermal micro-channeling system that is designed to offer simultaneous delivery of infused ingredients in a pain-free, no downtime treatment that can be administered by an aesthetician.
DermaFrac is marketed as an excellent alternative to fractional laser treatments and offers the added benefit of active infusion of topicals without anesthesia and at a significantly lower cost.
“With DermaFrac it is now possible to deliver high-grade active ingredients to the dermal layer like never before — and get better results,” said company president Jim Lafferty. “DermaFrac can infuse anti-aging peptides, skin lighteners, hyaluronic acid moisturizers, acne treatment solutions, and more.”
The DermaFrac system is said to use a unique combination of technologies to help enable improved topical infusion. The precision-controlled DermaFrac hand piece is designed to pull the skin under vacuum into contact with hundreds of micro-needles that painlessly penetrate through the epidermis and into the upper dermis (the papillary layer). DermaFrac micro-channels aim to create pathways for introducing the infusion solution into the area of the skin that is most beneficial to the natural rejuvenating process.
“The depth of the needles on the DermaFrac hand piece has been carefully selected
so that the channels are created just below the dermal-epidermal junction and just above capillaries and nerve endings. This ensures no bleeding or pain,” said Lafferty.
In addition, the specially formulated viscosity and molecular size of DermaFrac’s
topical solutions help to further maximize the skin rejuvenation process.
“By combining precisely calibrated needle penetration, unprecedented infusion capability, and the latest in topical solution technology, DermaFrac™ takes infusion technology to a whole new level,” Lafferty said.
Source: Genesis Biosystems, www.genesisbiosystems.com
